GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways
April 04, 2023 18:05 ET
|
Novotech
SINGAPORE, April 04, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO has commissioned GlobalData to report on the evolving FDA approval processes for biotechs in Asia...
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
March 23, 2023 06:30 ET
|
Orange Grove Bio
CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced that it has established new strategic collaborations with the Yonsei...
EvolveImmune Therapeutics Presents New Preclinical Data Demonstrating Improved Anti-Tumor Potential of Novel Costimulatory T Cell Engager Platform at Festival of Biologics Immunotherapy World Congress
March 22, 2023 07:00 ET
|
EvolveImmune
Company Unveils EVOLVE-105 Program, A Best-in-Class CD20xCD3 Multispecific Antibody Designed to Concurrently Drive CD2 Costimulation to Improve the Treatment of B cell Malignancies Expanding...
BrightInsight Named to Fierce Medtech’s 2022 Fierce 15 List
March 20, 2023 13:45 ET
|
BrightInsight
SAN JOSE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today that...
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
March 17, 2023 07:00 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) together with Cancer Research Horizons, the innovation engine at the core of the world’s largest private...
Monthly information on share capital and company voting rights
March 15, 2023 17:02 ET
|
Cellectis Inc.
NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Cellectis Announces Poster Presentation on TALEN®-edited MUC1 CAR T-cells Targeting Triple Negative Breast Cancer at the American Association of Cancer Research (AACR) Annual Meeting
March 14, 2023 17:00 ET
|
Cellectis Inc.
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Culture Biosciences Focuses Technology and Service Platform on Biologics
March 14, 2023 08:00 ET
|
Culture Biosciences
San Francisco, March 14, 2023 (GLOBE NEWSWIRE) -- SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) – Culture Biosciences today announced that it is increasing its focus on upstream bioprocess...
2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund Palo Santo
March 09, 2023 10:19 ET
|
Palo Santo
CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness, psychedelics are a major focus at SXSW 2023,...
Remplissage aseptique de petits volumes haute précision
March 09, 2023 09:00 ET
|
Single Use Support
KUFSTEIN, Autriche, 09 mars 2023 (GLOBE NEWSWIRE) -- Habituellement, la distribution de petits volumes de médicaments de thérapie innovante (ATMP) dans des petits sacs à usage unique s'effectuait...